Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.

@article{Gnreux2016TwoyearOA,
  title={Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.},
  author={Philippe G{\'e}n{\'e}reux and Nicolas Bettinger and Bj{\"o}rn Redfors and Arthur K. C. Lee and Christopher Y Kim and Michael S. Lee and Richard Shlofmitz and Jeffrey W. Moses and Gregg Whitney Stone and Jeffrey W. Chambers},
  journal={Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions},
  year={2016},
  volume={88 3},
  pages={369-77}
}
OBJECTIVES We report 2-year outcomes of the Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions (ORBIT II) trial, with emphasis on the impact of stent type. BACKGROUND The ORBIT II trial demonstrated the safety and efficacy of the Diamondback 360° Coronary Orbital Atherectomy System (OAS; Cardiovascular Systems, Inc., St. Paul, MN) in the treatment of de novo, severely calcified coronary lesions. METHODS ORBIT II was a single-arm trial that enrolled 443… CONTINUE READING